Rheumatology
9
1
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
The Efficacy of Ultrasonication in Combination With Corticosteroid Intraarticular Injection for Arthritis
An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis
PLAY Therapy Intervention: Re-Modelling Patient Experience (The PLAYTIME Study)
Leap Motion Based Gamefication Exercises in the Individuals With Systemic Sclerosis
Interest of a Nursing Consultation in the Empowerment of the Patient With Rheumatoid Arthritis in the Management of His Subcutaneous Biotherapy
Cardiovascular Risk and Chronic Inflammatory Rheumatism
Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory Disease
Observational Study Rheumatological Manifestations Associated With Endometriosis
Empowering Physicians With Evidence-Based Decision Support for Pediatric Rheumatology